Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

REGENXBIO Total Assets 2014-2020 | RGNX

REGENXBIO total assets from 2014 to 2020. Total assets can be defined as the sum of all assets on a company's balance sheet.
  
REGENXBIO Annual Total Assets
(Millions of US $)
2019 $498
2018 $544
2017 $199
2016 $173
2015 $221
2014 $3
2013 $3
REGENXBIO Quarterly Total Assets
(Millions of US $)
2020-03-31 $464
2019-12-31 $498
2019-09-30 $509
2019-06-30 $529
2019-03-31 $519
2018-12-31 $544
2018-09-30 $515
2018-06-30 $336
2018-03-31 $317
2017-12-31 $199
2017-09-30 $209
2017-06-30 $224
2017-03-31 $224
2016-12-31 $173
2016-09-30 $196
2016-06-30 $206
2016-03-31 $215
2015-12-31 $221
2015-09-30 $227
2015-06-30 $0
2015-03-31 $0
2014-12-31 $0
2014-09-30 $0
2013-12-31 $3
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $1.397B $0.035B
REGENXBIO Inc. is a biotechnology company. The Company focuses on the development, commercialization and licensing of recombinant adeno-associated virus gene therapy. Its products candidates include RGX-501, for the treatment of homozygous familial hypercholesterolemia which uses the AAV8 vector to deliver the human low-density lipoprotein receptor gene to liver cells; RGX-111, for the treatment of Mucopolysaccharidosis Type I which uses the AAV9 vector to deliver the human a-l-iduronidase gene to the central nervous system; RGX-121, for the treatment of Mucopolysaccharidosis Type II; RGX-314, for the treatment of wet age-related macular degeneration and RGX-321, for the treatment of X-linked retinitis pigmentosa. REGENXBIO Inc. is headquartered in Rockville, Maryland.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $130.003B 14.31
Gilead Sciences (GILD) United States $93.325B 12.10
CSL (CSLLY) Australia $90.047B 0.00
Vertex Pharmaceuticals (VRTX) United States $71.822B 49.38
Regeneron Pharmaceuticals (REGN) United States $66.482B 25.63
Illumina (ILMN) United States $52.673B 54.13
Biogen (BIIB) United States $49.381B 8.45
Seattle Genetics (SGEN) United States $26.839B 0.00
Alexion Pharmaceuticals (ALXN) United States $25.124B 10.79
Moderna (MRNA) United States $22.233B 0.00
Incyte (INCY) United States $21.483B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $20.519B 0.00
BioMarin Pharmaceutical (BMRN) United States $20.111B 182.31
Genmab (GMAB) Denmark $19.375B 15.96
Genmab (GNMSF) Denmark $17.902B 53.15
Alnylam Pharmaceuticals (ALNY) United States $15.759B 0.00
Bio-Rad Laboratories (BIO.B) United States $13.825B 62.93
Exact Sciences (EXAS) United States $13.378B 0.00
BeiGene (BGNE) Cayman Islands $13.074B 0.00
Galapagos (GLPG) Belgium $12.943B 38.33
Sarepta Therapeutics (SRPT) United States $11.623B 0.00
BioNTech SE (BNTX) Germany $11.576B 0.00
QIAGEN (QGEN) Netherlands $10.039B 29.19
Bio-Techne Corp (TECH) United States $9.916B 65.51
ARGENX SE-ADR (ARGX) Netherlands $9.857B 0.00
Horizon Therapeutics Public (HZNP) Ireland $9.314B 22.92
Guardant Health (GH) United States $8.029B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.310B 0.00
Immunomedics (IMMU) United States $7.271B 0.00
Exelixis (EXEL) United States $7.105B 24.91
Ascendis Pharma (ASND) Denmark $7.006B 0.00
Repligen (RGEN) United States $6.651B 116.65
Adaptive Biotechnologies (ADPT) United States $5.032B 0.00
Acceleron Pharma (XLRN) United States $5.027B 0.00
MyoKardia (MYOK) United States $4.820B 0.00
Emergent Biosolutions (EBS) United States $4.527B 29.67
Reata Pharmaceuticals (RETA) United States $4.501B 0.00
China Biologic Products (CBPO) China $4.327B 24.06
Ultragenyx Pharmaceutical (RARE) United States $4.325B 0.00
Mirati Therapeutics (MRTX) United States $4.273B 0.00
MorphoSys AG (MOR) Germany $4.265B 33.08
Zai Lab (ZLAB) China $4.250B 0.00
Global Blood Therapeutics (GBT) United States $4.073B 0.00
Blueprint Medicines (BPMC) United States $4.039B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.963B 86.60
Vir Biotechnology (VIR) United States $3.940B 0.00
Bluebird Bio (BLUE) United States $3.623B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.489B 0.00
Arena Pharmaceuticals (ARNA) United States $3.453B 0.00
Amicus Therapeutics (FOLD) United States $3.311B 0.00
Halozyme Therapeutics (HALO) United States $3.205B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.172B 0.00
Denali Therapeutics (DNLI) United States $3.044B 0.00
NeoGenomics (NEO) United States $2.871B 209.69
Viela Bio (VIE) United States $2.802B 0.00
UniQure (QURE) Netherlands $2.782B 0.00
Alkermes (ALKS) Ireland $2.648B 52.13
Insmed (INSM) United States $2.614B 0.00
Novavax (NVAX) United States $2.565B 0.00
Amarin (AMRN) Ireland $2.560B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.526B 0.00
Alector (ALEC) United States $2.415B 0.00
Fate Therapeutics (FATE) United States $2.399B 0.00
Principia Biopharma (PRNB) United States $2.070B 0.00
Inovio Pharmaceuticals (INO) United States $1.965B 0.00
Eidos Therapeutics (EIDX) United States $1.909B 0.00
Ligand Pharmaceuticals (LGND) United States $1.895B 73.78
Epizyme (EPZM) United States $1.762B 0.00
Zymeworks (ZYME) Canada $1.750B 0.00
Adverum Biotechnologies (ADVM) United States $1.675B 0.00
Sangamo Therapeutics (SGMO) United States $1.623B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.547B 0.00
Mesoblast (MESO) Australia $1.520B 0.00
Twist Bioscience (TWST) United States $1.519B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.516B 0.00
Editas Medicine (EDIT) United States $1.510B 0.00
Akcea Therapeutics (AKCA) United States $1.503B 0.00
PHARMA MAR SA (PHMMF) Spain $1.494B 0.00
I-Mab (IMAB) China $1.472B 0.00
Beam Therapeutics (BEAM) United States $1.448B 0.00
Zealand Pharma (ZEAL) Denmark $1.438B 0.00
Arcus Biosciences (RCUS) United States $1.437B 0.00
Zealand Pharma (ZLDPF) Denmark $1.412B 0.00
NGM Biopharmaceuticals (NGM) United States $1.390B 0.00
Intra-Cellular Therapies (ITCI) United States $1.378B 0.00
Coherus BioSciences (CHRS) United States $1.337B 9.34
Arvinas (ARVN) United States $1.314B 0.00
Cytokineticsorporated (CYTK) United States $1.225B 0.00
Revance Therapeutics (RVNC) United States $1.223B 0.00
Mersana Therapeutics (MRSN) United States $1.191B 0.00
Compugen (CGEN) Israel $1.171B 0.00
Myriad Genetics (MYGN) United States $1.156B 59.62
Intellia Therapeutics (NTLA) United States $1.147B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.969B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.942B 0.00
Athenex (ATNX) United States $0.929B 0.00
Pharming Group (PHGUF) Netherlands $0.895B 0.00
Sorrento Therapeutics (SRNE) United States $0.868B 0.00
Cue Biopharma (CUE) United States $0.815B 0.00
Heska (HSKA) United States $0.811B 0.00
Cellectis S.A (CLLS) France $0.753B 0.00
Cara Therapeutics (CARA) United States $0.752B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.747B 0.00
Kala Pharmaceuticals (KALA) United States $0.746B 0.00
NextCure (NXTC) United States $0.740B 0.00
Codexis (CDXS) United States $0.733B 0.00
Morphic Holding (MORF) United States $0.731B 0.00
NantKwest (NK) United States $0.729B 0.00
Retrophin (RTRX) United States $0.722B 0.00
Alcobra (ARCT) United States $0.718B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.709B 0.00
Kadmon Holdings (KDMN) United States $0.690B 0.00
Vericel (VCEL) United States $0.660B 122.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.660B 0.00
Sinovac Biotech (SVA) China $0.640B 17.03
Stemline Therapeutics (STML) United States $0.638B 0.00
Dynavax Technologies (DVAX) United States $0.632B 0.00
Bellus Health (BLU) Canada $0.630B 0.00
Agenus (AGEN) United States $0.629B 0.00
Castle Biosciences (CSTL) United States $0.626B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.625B 5.36
Syndax Pharmaceuticals (SNDX) United States $0.590B 0.00
DBV Technologies S.A (DBVT) France $0.573B 0.00
Frequency Therapeutics (FREQ) United States $0.573B 0.00
Athersys (ATHX) United States $0.572B 0.00
Intrexon (PGEN) United States $0.561B 0.00
UROGEN PHARMA (URGN) United States $0.547B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.533B 0.00
MeiraGTx Holdings (MGTX) United States $0.523B 0.00
Cel-Sci (CVM) United States $0.522B 0.00
AnaptysBio (ANAB) United States $0.519B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.518B 0.00
Clovis Oncology (CLVS) United States $0.514B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.491B 0.00
Scholar Rock Holding (SRRK) United States $0.486B 0.00
BioDelivery Sciences (BDSI) United States $0.477B 25.10
Anika Therapeutics (ANIK) United States $0.471B 15.13
VBI Vaccines (VBIV) United States $0.466B 0.00
AC Immune SA (ACIU) Switzerland $0.455B 0.00
Merus (MRUS) Netherlands $0.448B 0.00
Prothena (PRTA) Ireland $0.444B 0.00
Puma Biotechnology (PBYI) United States $0.435B 0.00
Syros Pharmaceuticals (SYRS) United States $0.433B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.428B 0.00
Protagonist Therapeutics (PTGX) United States $0.425B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.408B 0.00
Albireo Pharma (ALBO) United States $0.396B 0.00
Precision BioSciences (DTIL) United States $0.387B 0.00
MiMedx (MDXG) United States $0.387B 0.00
PDL BioPharma (PDLI) United States $0.372B 319.00
CytomX Therapeutics (CTMX) United States $0.370B 0.00
Seres Therapeutics (MCRB) United States $0.365B 0.00
Avid Bioservices (CDMO) United States $0.364B 0.00
ANI Pharmaceuticals (ANIP) United States $0.364B 7.21
Selecta Biosciences (SELB) United States $0.348B 0.00
Kamada (KMDA) Israel $0.347B 14.44
WAVE Life Sciences (WVE) Singapore $0.336B 0.00
OSMOTICA PHARM (OSMT) United States $0.324B 0.00
Geron (GERN) United States $0.321B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.306B 0.00
Verastem (VSTM) United States $0.304B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.295B 0.00
MannKind (MNKD) United States $0.294B 0.00
Menlo Therapeutics (MNLO) United States $0.290B 0.00
ChromaDex (CDXC) United States $0.283B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.281B 0.00
Liquidia Technologies (LQDA) United States $0.274B 0.00
Starpharma Holdings (SPHRY) Australia $0.266B 0.00
Affimed (AFMD) Germany $0.260B 0.00
Cellular Biomedicine (CBMG) United States $0.258B 0.00
HOOKIPA Pharma (HOOK) United States $0.254B 0.00
Spero Therapeutics (SPRO) United States $0.254B 0.00
Pfenex (PFNX) United States $0.250B 0.00
Fortress Biotech (FBIO) United States $0.249B 0.00
ADMA Biologics Inc (ADMA) United States $0.247B 0.00
Prometic Life Sciences (LMNL) Canada $0.247B 0.00
Abeona Therapeutics (ABEO) United States $0.245B 0.00
XOMA (XOMA) United States $0.239B 0.00
Northwest Biotherapeutics (NWBO) United States $0.238B 0.00
Exicure (XCUR) United States $0.237B 0.00
Sutro Biopharma (STRO) United States $0.236B 0.00
Gritstone Oncology (GRTS) United States $0.234B 0.00
POXEL SA FRANCE (PXXLF) France $0.217B 0.00
Aduro Biotech (ADRO) United States $0.208B 0.00
IVERIC Bio (ISEE) United States $0.203B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.202B 3.05
ARAVIVE, INC (ARAV) United States $0.201B 0.00
GENFIT S.A (GNFT) France $0.197B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.197B 0.00
Pluristem Therapeutics (PSTI) Israel $0.197B 0.00
TELA Bio (TELA) United States $0.194B 0.00
Kindred Biosciences (KIN) United States $0.194B 0.00
VTv Therapeutics (VTVT) United States $0.191B 0.00
IBio (IBIO) United States $0.185B 0.00
Strongbridge Biopharma (SBBP) United States $0.184B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.182B 0.00
Aytu Bioscience (AYTU) United States $0.182B 0.00
Five Prime Therapeutics (FPRX) United States $0.179B 0.00
Orgenesis (ORGS) United States $0.172B 0.00
Aptinyx (APTX) United States $0.169B 0.00
Celyad SA (CYAD) Belgium $0.165B 0.00
Dyadic (DYAI) United States $0.162B 0.00
Biofrontera AG (BFRA) Germany $0.159B 0.00
Cerecor (CERC) United States $0.155B 0.00
Cidara Therapeutics (CDTX) United States $0.150B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.145B 0.00
CorMedix Inc (CRMD) United States $0.143B 0.00
Arbutus Biopharma (ABUS) Canada $0.142B 0.00
Trevena (TRVN) United States $0.140B 0.00
PHASEBIO PHARMA (PHAS) United States $0.140B 0.00
Enzo Biochem (ENZ) United States $0.138B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.136B 0.00
Theratechnologies (THTX) Canada $0.135B 0.00
Antibe Therapeutics (ATBPF) Canada $0.132B 0.00
Cyclerion Therapeutics (CYCN) United States $0.131B 0.00
VolitionRX (VNRX) United States $0.131B 0.00
Palatin Technologies (PTN) United States $0.130B 3.33
Applied Genetic Technologies (AGTC) United States $0.126B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.124B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.118B 0.00
AIT Therapeutics (XAIR) United States $0.116B 0.00
Checkpoint Therapeutics (CKPT) United States $0.116B 0.00
Lumos Pharma (LUMO) United States $0.115B 0.00
Protalix BioTherapeutics (PLX) Israel $0.112B 0.00
Eton Pharmaceuticals (ETON) United States $0.108B 0.00
Oncobiologics (OTLK) United States $0.106B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.103B 0.00
Windtree Therapeutics (WINT) United States $0.102B 0.00
Catalyst Biosciences (CBIO) United States $0.095B 0.00
Organovo Holdings (ONVO) United States $0.093B 0.00
AquaBounty Technologies (AQB) United States $0.089B 0.00
Clearside Biomedical (CLSD) United States $0.086B 0.00
AnPac Bio-Medical Science (ANPC) China $0.085B 0.00
SESEN BIO, INC (SESN) United States $0.083B 0.00
Adocia (ADOCY) France $0.080B 0.00
Celsion (CLSN) United States $0.079B 0.00
Synlogic (SYBX) United States $0.078B 0.00
Emmaus Life Sciences (EMMA) United States $0.074B 0.00
Proteostasis Therapeutics (PTI) United States $0.072B 0.00
DiaMedica Therapeutics (DMAC) United States $0.071B 0.00
Stealth BioTherapeutics (MITO) United States $0.070B 0.00
Happiness Biotech Group (HAPP) China $0.068B 0.00
Idera Pharmaceuticals (IDRA) United States $0.068B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.063B 0.00
Vaccinex (VCNX) United States $0.061B 0.00
Celldex Therapeutics (CLDX) United States $0.060B 0.00
CollPlant Holdings (CLGN) Israel $0.059B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.059B 0.00
Ecology Coatings (ABVC) United States $0.058B 0.00
Vascular Biogenics (VBLT) Israel $0.053B 0.00
Soligenix (SNGX) United States $0.051B 0.00
Apricus Biosciences (SEEL) United States $0.050B 0.00
Signal Genetics (MGEN) United States $0.049B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.048B 0.00
Cocrystal Pharma (COCP) United States $0.048B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.048B 0.00
Advaxis (ADXS) United States $0.047B 0.00
Prima BioMed (IMMP) Australia $0.043B 0.00
Pulmatrix (PULM) United States $0.042B 0.00
OvaScience (MLND) United States $0.041B 0.00
Cesca Therapeutics (THMO) United States $0.040B 0.00
AmpliPhi Biosciences (ARMP) United States $0.040B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.040B 0.00
TrovaGene (CRDF) United States $0.040B 0.00
Chanticleer Holdings (SONN) United States $0.037B 0.00
Acorda Therapeutics (ACOR) United States $0.036B 0.00
ATyr Pharma (LIFE) United States $0.035B 0.00
Evogene (EVGN) Israel $0.033B 0.00
TOCAGEN INC (TOCA) United States $0.030B 0.00
Curis (CRIS) United States $0.030B 0.00
Stellar Biotechnologies (EDSA) Canada $0.029B 0.00
BioCardia (BCDA) United States $0.028B 0.00
AEterna Zentaris (AEZS) United States $0.027B 0.00
Titan Pharmaceuticals (TTNP) United States $0.026B 0.00
Alimera Sciences (ALIM) United States $0.026B 0.00
Bionano Genomics (BNGO) United States $0.025B 0.00
Spherix (AIKI) United States $0.024B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.024B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.023B 0.00
Entera Bio (ENTX) Israel $0.022B 0.00
Novogen (KZIA) Australia $0.022B 0.00
VIVUS (VVUS) United States $0.019B 0.00
Aptevo Therapeutics (APVO) United States $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.019B 0.00
Genetic Technologies (GENE) Australia $0.018B 0.00
Unum Therapeutics (UMRX) United States $0.017B 0.00
TRACON Pharmaceuticals (TCON) United States $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
Neuralstem (SNCA) United States $0.008B 0.00
Prana Biotechnology (ATHE) Australia $0.008B 0.00
IMMURON (IMRN) Australia $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
BioPharmX (TMBR) United States $0.004B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00